Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

342 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19.
Farge D, Frere C, Connors JM, Khorana AA, Kakkar A, Ay C, Muñoz A, Brenner B, Prata PH, Brilhante D, Antic D, Casais P, Guillermo Esposito MC, Ikezoe T, Abutalib SA, Meillon-García LA, Bounameaux H, Pabinger I, Douketis J; International Initiative on Thrombosis and Cancer (ITAC) advisory panel. Farge D, et al. Lancet Oncol. 2022 Jul;23(7):e334-e347. doi: 10.1016/S1470-2045(22)00160-7. Lancet Oncol. 2022. PMID: 35772465 Free PMC article. Review.
Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study.
Meyer G, Marjanovic Z, Valcke J, Lorcerie B, Gruel Y, Solal-Celigny P, Le Maignan C, Extra JM, Cottu P, Farge D. Meyer G, et al. Among authors: farge d. Arch Intern Med. 2002 Aug 12-26;162(15):1729-35. doi: 10.1001/archinte.162.15.1729. Arch Intern Med. 2002. PMID: 12153376 Clinical Trial.
2008 French national guidelines for the treatment of venous thromboembolism in patients with cancer: report from the working group.
Farge D, Bosquet L, Kassab-Chahmi D, Mismetti P, Elalamy I, Meyer G, Cajfinger F, Desmurs-Clavel H, Elias A, Grange C, Hocini H, Legal G, Mahe I, Quéré I, Levesque H, Debourdeau P; SOR. Farge D, et al. Crit Rev Oncol Hematol. 2010 Jan;73(1):31-46. doi: 10.1016/j.critrevonc.2008.12.004. Crit Rev Oncol Hematol. 2010. PMID: 19801193 Review.
Therapy for cancer-related thromboembolism.
Frere C, Debourdeau P, Hij A, Cajfinger F, Nonan MN, Panicot-Dubois L, Dubois C, Farge D. Frere C, et al. Among authors: farge d. Semin Oncol. 2014 Jun;41(3):319-38. doi: 10.1053/j.seminoncol.2014.04.005. Epub 2014 May 4. Semin Oncol. 2014. PMID: 25023348 Review.
Prophylaxis of venous thromboembolism in cancer patients.
Frere C, Doucet L, Farge D. Frere C, et al. Among authors: farge d. Expert Rev Hematol. 2016 Jun;9(6):535-9. doi: 10.1586/17474086.2016.1172959. Epub 2016 May 3. Expert Rev Hematol. 2016. PMID: 27031534 Review.
342 results